Schedule:
Monday - Saturday - 0:00 - 0:00, Sunday - 0:00 - 0:00
  info@dummymail.com
  1237 654 443
  Login
Donate
Registry WebLink
Toggle navigation
Home
About Us
Who We Are
Advisory Board
Participating/Executive Members
Annual Returns
Member Institutions
Research
Research
SOP for Multicenter Studies
Ongoing Studies
Publication & Abstracts
Publication
Abstracts
Membership
Membership Information
Individual
Online Registration
List of Individual Members
Institutional
Online Registration
Education
Physician Webinar
Nursing Webinar
DEO Training
Guidelines
Patient Information
Patient Education
English
Hindi
Marathi
Malayalam
Kannada
Support Group Meeting
Patient Stories
Useful Links
News & Events
Announcements
Newsletter Archives
Annual Conference
2019
Conference presentations
2022
Scientific Program
Nurses Workshop
DEO Training Workshop
Patient Advocacy Session
Gallery
Day 1
Day 2
Day 3
Connect with us
Contact Us
Donate
Presentation
ACUTE LYMPHOBLASTIC LEUKEMIA
Know More
Topic:
Presenter:
Harry Iland
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Advances in B-ALL
Presenter:
Dr.Charles Mullighan
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Advances in Multiple Myeloma
Presenter:
Dr. Sundar Jagannath
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
AML Therapy Older Patients
Presenter:
Dr. Harry Erba
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
ACUTE MYELOID LEUKEMIA
Know More
Topic:
Antibody based immunotherapy in hematology
Presenter:
Dr Reetu Jain
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Bcl2 inhibitors and hematology
Presenter:
Dr.Atul Sharma
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Biology of Acute Myeloid Leukemia -Mutations and Clonal Architecture
Presenter:
Dr.Harry Erba
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Consensus _ Controversies Frontline therapy for CML
Presenter:
Dr.Timothy Hughes
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
ACUTE PROMYELOCYTIC LEUKEMIA
Know More
Topic:
Evolving Landscape of De- NovoAML Therapy
Presenter:
Dr.Farhad Ravandi
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Management of AYA ALL
Presenter:
Dr. Prashant Ganesan
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Management of Low risk MDS
Presenter:
Dr. Jina Bhattacharya
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Measurable (Minimal) Residual Disease in Acute Myeloid Leukemia
Presenter:
Dr.Harry Erba
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
MULTIPLE MYELOMA
Know More
Topic:
MRD in ALL Current Status and recent advances
Presenter:
Dr.Charles Mullighan
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Clinicians perspective
Presenter:
Dr.Sundar Jagannath
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Laboratory perspective
Presenter:
Dr.Prashant Tembhare
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Role of NGS in Myeloid Malignancies - Lab Perspective
Presenter:
Dr.Nikhil Patkar
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
CHRONIC MYELOID LEUKEMIA
Know More
Topic:
TKI toxicities
Presenter:
Dr.Dinesh Bhurani
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Treat newly diagnosed Multiple Myeloma
Presenter:
Dr.Anoop Devasia
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Treatment Free Remission -is it ready for the clinics
Presenter:
Dr.Timothy Hughes
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Understanding ETP-ALL - Biology and its implications
Presenter:
Dr.Manju Sengar
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
MYELODYSPLASTIC SYNDROME
Know More
Topic:
MRD in ALL Current Status and recent advances
Presenter:
Dr.Charles Mullighan
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Clinicians perspective
Presenter:
Dr.Sundar Jagannath
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Laboratory perspective
Presenter:
Dr.Prashant Tembhare
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Role of NGS in Myeloid Malignancies - Lab Perspective
Presenter:
Dr.Nikhil Patkar
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
MRD / RECENT ADVANCES IN HEMATOLOGY
Know More
Topic:
MRD in ALL Current Status and recent advances
Presenter:
Dr.Charles Mullighan
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Clinicians perspective
Presenter:
Dr.Sundar Jagannath
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Laboratory perspective
Presenter:
Dr.Prashant Tembhare
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Role of NGS in Myeloid Malignancies - Lab Perspective
Presenter:
Dr.Nikhil Patkar
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
BREAKTHROUGH AND RECENTLY APPROVED DRUGS
Know More
Topic:
MRD in ALL Current Status and recent advances
Presenter:
Dr.Charles Mullighan
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Clinicians perspective
Presenter:
Dr.Sundar Jagannath
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
MRD in Myeloma Laboratory perspective
Presenter:
Dr.Prashant Tembhare
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
Know More
Topic:
Role of NGS in Myeloid Malignancies - Lab Perspective
Presenter:
Dr.Nikhil Patkar
Institute:
Institute of Hematology & Royal Prince Alfred Hospital
×
Acute Promyelocytic Leukemia-Biology & Management
No Support
×
Advances in B-ALL
No Support
×
Advances in Multiple Myeloma
No Support
×
AML Therapy Older Patients
No Support
×
Antibody based immunotherapy in hematology
No Support
×
Bcl2 inhibitors and hematology
No Support
×
Biology of Acute Myeloid Leukemia
No Support
×
Consensus _ Controversies Frontline therapy for CML
No Support
×
Evolving Landscape of De- NovoAML Therapy
No Support
×
Management of AYA ALL
No Support
×
Management of Low risk MDS
No Support
×
Measurable (Minimal) Residual Disease in Acute Myeloid Leukemia
No Support
×
MRD in ALL Current Status and recent advances
No Support
×
MRD in Myeloma Clinicians perspective
No Support
×
MRD in Myeloma Laboratory perspective
No Support
×
Role of NGS in Myeloid Malignancies - Lab Perspective
No Support
×
TKI toxicities
No Support
×
Treat newly diagnosed Multiple Myeloma
No Support
×
Treatment Free Remission -is it ready for the clinics
No Support
×
Understanding ETP-ALL - Biology and its implications
No Support